MedPacto, Inc. (KOSDAQ:235980)
South Korea
· Delayed Price · Currency is KRW 3,110.00
+50.00 (1.63%)
Apr 1, 2025, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 106.60 billion as of April 1, 2025. Its market cap has decreased by -78.29% in one year.
Market Cap
106.60B
Enterprise Value
53.06B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,110.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 106.60B, a decrease of -70.59%. That is a compound annual growth rate of -20.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.17T |
| Celltrion | 36.29T |
| ALTEOGEN | 18.97T |
| Yuhan | 8,537.79B |
| SK Biopharmaceuticals | 7,776.51B |
| HLB Co., Ltd. | 7,225.34B |
| Sam Chun Dang Pharm. | 3,930.51B |
| PharmaResearch | 3,449.36B |